Supreme Court Denies Review Of Cost Sharing Assistance Program - Healthcare
The U.S. Supreme Court recently declined to review a Second Circuit decision that blocked Pfizer from implementing a cost sharing assistance program.
Stay updated with breaking news from Direct Copay Assistance Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Supreme Court recently declined to review a Second Circuit decision that blocked Pfizer from implementing a cost sharing assistance program.
The U.S. Supreme Court recently declined to review a Second Circuit decision that blocked Pfizer from implementing a cost sharing assistance program. Pfizer had sought to cover...
This year, the Office of Inspector General ("OIG") and at least two federal courts have taken a clear stance against pharmaceutical manufacturers' attempts to offer cost-sharing subsidies...
The drugmaker may not pay Medicare beneficiaries' out-of-pocket costs for a heart medication priced at $225,000 a year, a federal appeals court decided.
By Jonathan Stempel NEW YORK (Reuters) - A federal appeals court on Monday rejected Pfizer Inc's challenge to a U.S. anti-kickback law that the drugma...